|
Market Closed -
Euronext Paris
11:55:00 2026-10-23 am EDT
|
5-day change | 1st Jan Change | ||
| 151.20 EUR | -0.66% |
|
+1.48% | +27.06% |
| Oct. 22 | Ipsen S.A. Upgrades Financial Guidance for the Full-Year 2026 | CI |
| Oct. 22 | Ipsen S.A., Q3 2026 Sales/ Trading Statement Call, Oct 22, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPSEN | Other Pharmaceuticals | -0.66% | +1.48% | +27.06% | +24.14% | +69.89% | 13.88B |  |  | |
- Stock Market
- Stocks
- IPN Stock
- Charts Ipsen
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
